Circulomics

company

About

Circulomics is a biotechnology company that uses micro- and nanotechnologies to streamline genomics research and clinical diagnostics.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$1.50M
Industries
Biotechnology,Genetics,Health Care
Founded date
Apr 21, 2009
Number Of Employee
1 - 10
Operating Status
Active

Circulomics is a Maryland biotechnology company located within IMET's Harbor Launch Incubator. To date, Circulomics has received nearly $8M in funding from NIH and Maryland TEDCO to develop innovative platforms for nucleic acid sample preparation, microRNA profiling, and single molecule analysis that will drive the research and clinical translation of genomics technologies from sequencing to expression profiling and biomarker analysis.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$5M
Circulomics has raised a total of $5M in funding over 2 rounds. Their latest funding was raised on Sep 30, 2020 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 30, 2020 Grant $1.60M 1 National Human Genome Research Institute Detail
Sep 15, 2017 Grant $1.50M 1 Detail
Feb 7, 2017 Grant $1.50M 1 Detail
Sep 12, 2011 Grant $400K 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Circulomics is funded by 2 investors. National Human Genome Research Institute and National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Human Genome Research Institute Yes Grant
National Institutes of Health Grant